NICE issues draft guidance on abiraterone for prostate cancer

(Source: PharmacoEconomics and Outcomes News)...

Share |

Published By: MedWorm/RelationshipIssues - Wednesday, 22 February

Comments

Please Login or Register to make a comment

Older News
Vote! Splits remain over draft Rio+20 conclusions MedWorm/RelationshipIssues (Yesterday) - The latest version of the Rio+20 draft outcome document will be published next week, amidst...
Vote! U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer CancerCompass/Top (Yesterday) - Benefits of prostate-specific antigen screening don't outweigh harms, panel contends...

vBulletin statistics